Publications by authors named "Emil Tanghetti"

Claim this Profile
C
Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne: A Pooled Analysis by Age.
Leon H Kircik, Julie C Harper, Hilary Baldwin, Lawrence F Eichenfield, Emil A Tanghetti

J Drugs Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resolving Hyperkeratotic Psoriasis: Mechanisms of Action and Additive Effects of Fixed-Combination Halobetasol Propionate and Tazarotene.
Emil A Tanghetti, Mark G Lebwohl, Linda Stein Gold, Lawrence Green, Zoe D Draelos

J Drugs Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Profile of Halobetasol Propionate 0.01%/ Tazarotene 0.045% Lotion in Patients With Hyperkeratotic Plaque Psoriasis.
Emil Tanghetti, Linda Stein Gold, Edward Lain, Abby Abby

J Drugs Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% for Acne: Results From A 6-Month Open-Label Study.
Zoe Diana Draelos, Mahmoud Ghannoum, Linda Stein Gold, Julie C Harper, Hilary Baldwin, Emil A Tanghetti

J Drugs Dermatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Acne With a 1726 nm Laser, Air Cooling, and Real-Time Temperature Monitoring, Software-Assisted Power Adjustment to Achieve a Temperature Endpoint With Selective Sebaceous Gland Photothermolysis.
Emil A Tanghetti, Rafael Sierra, Michael Estes, Aubrey Eck, Alfred Intintoli

Lasers Surg Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Acne Improvements With Fixed-Combination Topical Therapy: Analysis of the First 4 Weeks of Treatment.
Steven R Feldman, Katie Lovell, Robin Yi, Julie Harper, Hilary Baldwin, Emil Tanghetti

J Drugs Dermatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne in Children and Adolescents.
Lawrence F Eichenfield, Adelaide A Hebert, Julie C Harper, Hilary Baldwin, Neal Bhatia, Emil A Tanghetti

J Drugs Dermatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement.
McKenzie A Dirr, Areeba Ahmed, Daniel I Schlessinger, Misha Haq, Victoria Shi, Emil A Tanghetti

JAMA Dermatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis.
Leon H Kircik, Linda Stein Gold, Michael Gold, Jonathan S Weiss, Julie C Harper, Emil A Tanghetti

Dermatol Ther (Heidelb)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin.
Emil A Tanghetti, Joshua A Zeichner, Michael Gold, Neil Sadick, Fran E Cook-Bolden

J Dermatolog Treat· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials.
Zoe D Draelos, Emil A Tanghetti, Leon H Kircik, Neal Bhatia, Joshua A Zeichner

J Dermatolog Treat· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Season on Efficacy and Tolerability of Tazarotene 0.045% Lotion for the Treatment of Acne.
Jerry Tan, Zoe D Draelos, Melinda J Gooderham, Andrew F Alexis, Emmy Graber, Emil A Tanghetti

J Clin Aesthet Dermatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanin-dependent tissue interactions induced by a 755-nm picosecond-domain laser: complementary visualization by optical imaging and histology.
Kevin Jacobsen, Vinzent Kevin Ortner, Gabriella Louise Fredman, Rikke Louise Christensen, Christine Dierickx, Emil Tanghetti

Lasers Med Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study.
Lawrence F Eichenfield, Linda Stein Gold, Leon H Kircik, William P Werschler, Kenneth Beer, Emil A Tanghetti

Pediatr Dermatol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in Psoriatic Disease Addressed by Fixed-Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion.
Leon Kircik, Emil A Tanghetti, Adam Friedman, Kristine Kucera, Abby Jacobson

J Clin Aesthet Dermatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SUPPLEMENT INDIVIDUAL ARTICLES: Update on Truncal Acne: A Review of Treatments for a Neglected Disease and the Re-Emergence of Tazarotene.
Naiem Issa, Zoe Draelos, Emil Tanghetti, Leon Kircik

J Drugs Dermatol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vehicle Formulation Impacts Tolerability and Patient Preference: Comparison of Tretinoin Branded Lotion and Generic Cream.
Zoe Draelos, Emil Tanghetti, Eric Guenin

J Drugs Dermatol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tazarotene 0.045% Lotion for Females With Acne: Analysis of Two Adult Age Groups.
Linda Stein Gold, Leon Kircik, Hilary Baldwin, Valerie Callender, Emil Tanghetti

J Drugs Dermatol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Rheology Predicts Improved Spreadability of Tazarotene 0.045% Lotion Versus Trifarotene 0.005% Cream.
Zoe Draelos, Emil Tanghetti, William Werschler, Leon Kircik, Arturo Angel

J Drugs Dermatol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
Linda Stein Gold, Hilary Baldwin, Leon H Kircik, Jonathan S Weiss, David M Pariser, Emil A Tanghetti

Am J Clin Dermatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits.
Mark G Lebwohl, Emil A Tanghetti, Linda Stein Gold, James Q Del Rosso, Nelly K Gilyadov

Dermatol Ther (Heidelb)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-Combination Halobetasol Propionate/Tazarotene Lotion for Psoriasis in Patients With 3%-5% Affected Body Surface Area.
Emil A Tanghetti, Neal Bhatia, Scott Drew, Abby Jacobson

J Drugs Dermatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tazarotene 0.045% Lotion for Moderate-to-Severe Acne Patients: Pooled Phase 3 Analysis by Age and Sex.
Lawrence J Green, James Q Del Rosso, Emil A Tanghetti, Eric Guenin

J Drugs Dermatol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical Oxymetazoline Hydrochloride Cream 1% for the Treatment of Persistent Facial Erythema of Rosacea in Adults: A Comprehensive Review of Current Evidence.
James Q Del Rosso, Emil Tanghetti

J Clin Aesthet Dermatol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).
James Q Del Rosso, Emil Tanghetti, Guy Webster, Linda Stein Gold, Diane Thiboutot

J Clin Aesthet Dermatol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis